Literature DB >> 21168124

Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia.

Gregory P Strauss1, Michael J Frank, James A Waltz, Zuzana Kasanova, Ellen S Herbener, James M Gold.   

Abstract

BACKGROUND: Negative symptoms are core features of schizophrenia (SZ); however, the cognitive and neural basis for individual negative symptom domains remains unclear. Converging evidence suggests a role for striatal and prefrontal dopamine in reward learning and the exploration of actions that might produce outcomes that are better than the status quo. The current study examines whether deficits in reinforcement learning and uncertainty-driven exploration predict specific negative symptom domains.
METHODS: We administered a temporal decision-making task, which required trial-by-trial adjustment of reaction time to maximize reward receipt, to 51 patients with SZ and 39 age-matched healthy control subjects. Task conditions were designed such that expected value (probability × magnitude) increased, decreased, or remained constant with increasing response times. Computational analyses were applied to estimate the degree to which trial-by-trial responses are influenced by reinforcement history.
RESULTS: Individuals with SZ showed impaired Go learning but intact NoGo learning relative to control subjects. These effects were most pronounced in patients with higher levels of negative symptoms. Uncertainty-based exploration was substantially reduced in individuals with SZ and selectively correlated with clinical ratings of anhedonia.
CONCLUSIONS: Schizophrenia patients, particularly those with high negative symptoms, failed to speed reaction times to increase positive outcomes and showed reduced tendency to explore when alternative actions could lead to better outcomes than the status quo. Results are interpreted in the context of current computational, genetic, and pharmacological data supporting the roles of striatal and prefrontal dopamine in these processes.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168124      PMCID: PMC3039035          DOI: 10.1016/j.biopsych.2010.10.015

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  57 in total

1.  Abstract reward and punishment representations in the human orbitofrontal cortex.

Authors:  J O'Doherty; M L Kringelbach; E T Rolls; J Hornak; C Andrews
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

2.  Associative learning in deficit and nondeficit schizophrenia.

Authors:  Márta Farkas; Patricia Polgár; Oguz Kelemen; János Réthelyi; István Bitter; Catherine E Myers; Mark A Gluck; Szabolcs Kéri
Journal:  Neuroreport       Date:  2008-01-08       Impact factor: 1.837

3.  Linking animal models of psychosis to computational models of dopamine function.

Authors:  Andrew J Smith; Ming Li; Suzanna Becker; Shitij Kapur
Journal:  Neuropsychopharmacology       Date:  2006-05-10       Impact factor: 7.853

4.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

5.  Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro.

Authors:  J R Wickens; A J Begg; G W Arbuthnott
Journal:  Neuroscience       Date:  1996-01       Impact factor: 3.590

6.  Variation in dopamine genes influences responsivity of the human reward system.

Authors:  Jean-Claude Dreher; Philip Kohn; Bhaskar Kolachana; Daniel R Weinberger; Karen Faith Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

7.  Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.

Authors:  Stefano Palminteri; Maël Lebreton; Yulia Worbe; David Grabli; Andreas Hartmann; Mathias Pessiglione
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-22       Impact factor: 11.205

Review 8.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

Review 9.  Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.

Authors:  Edmund T Rolls; Marco Loh; Gustavo Deco; Georg Winterer
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

10.  How to find the way out from four rooms? The learning of "chaining" associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia.

Authors:  Patricia Polgár; Márta Farkas; Orsolya Nagy; Oguz Kelemen; János Réthelyi; István Bitter; Catherine E Myers; Mark A Gluck; Szabolcs Kéri
Journal:  Schizophr Res       Date:  2007-08-10       Impact factor: 4.939

View more
  100 in total

Review 1.  From reinforcement learning models to psychiatric and neurological disorders.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Nat Neurosci       Date:  2011-02       Impact factor: 24.884

2.  Frontal theta reflects uncertainty and unexpectedness during exploration and exploitation.

Authors:  James F Cavanagh; Christina M Figueroa; Michael X Cohen; Michael J Frank
Journal:  Cereb Cortex       Date:  2011-11-25       Impact factor: 5.357

Review 3.  Motivational Deficits in Schizophrenia and the Representation of Expected Value.

Authors:  James A Waltz; James M Gold
Journal:  Curr Top Behav Neurosci       Date:  2016

4.  Explicit and implicit reinforcement learning across the psychosis spectrum.

Authors:  Deanna M Barch; Cameron S Carter; James M Gold; Sheri L Johnson; Ann M Kring; Angus W MacDonald; Diego A Pizzagalli; J Daniel Ragland; Steven M Silverstein; Milton E Strauss
Journal:  J Abnorm Psychol       Date:  2017-04-13

5.  Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence.

Authors:  James M Gold; James A Waltz; Tatyana M Matveeva; Zuzana Kasanova; Gregory P Strauss; Ellen S Herbener; Anne G E Collins; Michael J Frank
Journal:  Arch Gen Psychiatry       Date:  2012-02

6.  Affective modulation of cognitive control is determined by performance-contingency and mediated by ventromedial prefrontal and cingulate cortex.

Authors:  Senne Braem; Joseph A King; Franziska M Korb; Ruth M Krebs; Wim Notebaert; Tobias Egner
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

7.  Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning.

Authors:  Morgane Milienne-Petiot; Kerin K Higa; Andrea Grim; Debbie Deben; Lucianne Groenink; Elizabeth W Twamley; Mark A Geyer; Jared W Young
Journal:  Eur Neuropsychopharmacol       Date:  2018-09-11       Impact factor: 4.600

Review 8.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

9.  Identifying cognitive remediation change through computational modelling--effects on reinforcement learning in schizophrenia.

Authors:  Matteo Cella; Anthony J Bishara; Evelina Medin; Sarah Swan; Clare Reeder; Til Wykes
Journal:  Schizophr Bull       Date:  2013-11-09       Impact factor: 9.306

10.  The processing of emotional stimuli during periods of limited attentional resources in schizophrenia.

Authors:  Gregory P Strauss; Lauren T Catalano; Katiah Llerena; James M Gold
Journal:  J Abnorm Psychol       Date:  2013-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.